[HTML][HTML] Microparticles, microspheres, and microcapsules for advanced drug delivery

M Lengyel, N Kállai-Szabó, V Antal, AJ Laki… - Scientia …, 2019 - mdpi.com
Microparticles, microspheres, and microcapsules are widely used constituents of
multiparticulate drug delivery systems, offering both therapeutic and technological …

[PDF][PDF] Simulated biological fluids with possible application in dissolution testing

MRC Marques, R Loebenberg, M Almukainzi - Dissolution Technol, 2011 - academia.edu
This literature review is a compilation of the composition and, in most cases, the preparation
instructions for simulated biological fluids that may be used as dissolution media in the …

Simulated biological fluids–a systematic review of their biological relevance and use in relation to inhalation toxicology of particles and fibres

E Innes, HHP Yiu, P McLean, W Brown… - Critical Reviews in …, 2021 - Taylor & Francis
The use of simulated biological fluids (SBFs) is a promising in vitro technique to better
understand the release mechanisms and possible in vivo behaviour of materials, including …

Formation, characterization, and fate of inhaled drug nanoparticles

J Zhang, L Wu, HK Chan, W Watanabe - Advanced drug delivery reviews, 2011 - Elsevier
Nanoparticles bring many benefits to pulmonary drug delivery applications, especially for
systemic delivery and drugs with poor solubility. They have recently been explored in …

Pulmonary drug metabolism, clearance, and absorption

B Olsson, E Bondesson, L Borgström… - … pulmonary drug delivery, 2011 - Springer
Delivering therapeutic agents to the lungs requires a deep understanding of the kinetics and
dynamics of drugs in this biologically and physiologically complex system. In this chapter …

[HTML][HTML] In vitro investigations of human bioaccessibility from reference materials using simulated lung fluids

A Pelfrêne, MR Cave, J Wragg, F Douay - International journal of …, 2017 - mdpi.com
An investigation for assessing pulmonary bioaccessibility of metals from reference materials
is presented using simulated lung fluids. The objective of this paper was to contribute to an …

[HTML][HTML] Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

JE Hastedt, P Bäckman, AR Clark, W Doub, A Hickey… - 2016 - Springer
Abstract The Biopharmaceutics Classification System (BCS), developed in the 1990s for oral
immediate release drugs, is utilized by R&D scientists and regulators to streamline product …

Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma

Y Xie, NH Kim, V Nadithe, D Schalk, A Thakur… - Journal of Controlled …, 2016 - Elsevier
Asthma is a worldwide health problem. Activated T cells (ATCs) in the lung, particularly T
helper 2 cells (Th 2), are strongly associated with inducing airway inflammatory responses …

Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs

P Bäckman, S Arora, W Couet, B Forbes… - European Journal of …, 2018 - Elsevier
Prediction of local exposure following inhalation of a locally acting pulmonary drug is central
to the successful development of novel inhaled medicines, as well as generic equivalents …

[HTML][HTML] Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis

JEC Pacheco, T Yalovenko, A Riaz, N Kotov… - Journal of Controlled …, 2024 - Elsevier
Inhalation therapy treating severe infectious disease is among the more complex and
emerging topics in controlled drug release. Micron-sized carriers are needed to deposit …